News

All Releases
Tandem Diabetes Care Announces Upcoming Conference Presentation
Jun 20, 2019
SAN DIEGO --(BUSINESS WIRE)--Jun. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present at the BMO 2019 Prescriptions for Success Healthcare
CORRECTING and REPLACING Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Jun 13, 2019
Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups SAN FRANCISCO --(BUSINESS WIRE)--Jun. 13, 2019-- Fourth paragraph, fourth sentence of release dated June 9, 2019 , should read: Time spent below 70 mg/dL was 1.4 percent with Control-IQ technology compared to 1.9
Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
Jun 09, 2019
Significant Time-in-Range Improvements Demonstrated in Adult and Pediatric Age Groups SAN FRANCISCO --(BUSINESS WIRE)--Jun. 9, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced positive results from two studies of the
Tandem Diabetes Care Announces Conference Call Following Data Presentations at the ADA Scientific Sessions
Jun 07, 2019
SAN DIEGO --(BUSINESS WIRE)--Jun. 7, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will hold a conference call on Sunday, June 9, 2019 at 8:00pm Eastern Time ( 5:00pm Pacific Time ) following data
Tandem Diabetes Care Announces Upcoming Conference Presentations
May 13, 2019
SAN DIEGO --(BUSINESS WIRE)--May 13, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a Company update at the following upcoming investor conferences: Bank of America Merrill Lynch Healthcare
Tandem Diabetes Care Announces First Quarter 2019 Financial Results and Updated 2019 Financial Guidance
Apr 30, 2019
SAN DIEGO --(BUSINESS WIRE)--Apr. 30, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2019 and updated its financial guidance for the year ending December 31, 2019 .
Tandem Diabetes Care to Announce First Quarter 2019 Financial Results on April 30, 2019
Apr 16, 2019
SAN DIEGO --(BUSINESS WIRE)--Apr. 16, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2019 results after the financial markets close on Tuesday, April 30, 2019 .
Tandem Diabetes Care Approved as Insulin Pump Vendor for ADP in Ontario, Canada
Mar 07, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 7, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it is now registered as an approved vendor of insulin pumps and supplies under the Assistive Devices Program (ADP) in Ontario,
Tandem Diabetes Care Announces Upcoming Conference Presentations
Mar 06, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that John Sheridan , president and chief executive officer, will present at the following upcoming investor conferences: Cowen 39 th
Tandem Diabetes Care Announces Plan to Use Remote Software Update Tool in Ongoing Clinical Trial
Mar 06, 2019
SAN DIEGO --(BUSINESS WIRE)--Mar. 6, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly
Tandem Diabetes Care Announces Succession Plan for Chief Executive Officer and Board of Directors
Feb 26, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced a succession plan for its chief executive officer (CEO) and select members of its board of directors.
Tandem Diabetes Care Reports 2018 Financial Results and 2019 Financial Guidance
Feb 26, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 26, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter and year ended December 31, 2018 and financial guidance for the year ending December 31, 2019 .
Tandem Diabetes Care Appoints New Senior Vice President to Drive Expansion of Digital Health and Information Technology Initiatives
Feb 20, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 20, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Manuel Jaime as its new Senior Vice President, Technology and Digital Health .
t:slim X2 Insulin Pump First to Receive New ACE Pump Classification by FDA
Feb 14, 2019
SAN DIEGO --(BUSINESS WIRE)--Feb. 14, 2019-- Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration ( FDA ) has classified the t:slim X2™ insulin pump as the first in a new device category
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2018 Financial Results on February 26, 2019
Jan 21, 2019
SAN DIEGO --(BUSINESS WIRE)--Jan. 21, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2018 results after the financial markets close on Tuesday, February 26, 2019 .
Tandem Diabetes Care Announces Appointment of Rebecca Robertson as Board Member
Jan 03, 2019
SAN DIEGO --(BUSINESS WIRE)--Jan. 3, 2019-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Rebecca (Beckie) Robertson was appointed as an independent member of its board of directors.
Tandem Diabetes Care to Present at the Credit Suisse Healthcare Conference
Nov 13, 2018
SAN DIEGO --(BUSINESS WIRE)--Nov. 13, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that Kim Blickenstaff , President and Chief Executive Officer and Leigh Vosseller , EVP and Chief Financial Officer, will present at
Tandem Diabetes Care Honored in San Diego 2018 Top Workplaces Awards From San Diego Union-Tribune
Nov 12, 2018
SAN DIEGO --(BUSINESS WIRE)--Nov. 12, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced it has been named a top workplace in San Diego by The San Diego Union-Tribune and awarded a “Future Forward” 2018 Top Workplaces
Tandem Diabetes Care Announces Upcoming Conference Presentations
Nov 08, 2018
SAN DIEGO --(BUSINESS WIRE)--Nov. 8, 2018-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present at the following upcoming investor conferences: Stifel 2018 Healthcare Conference on Tuesday, November 13,
Tandem Diabetes Care Reports Third Quarter 2018 Financial Results
Nov 01, 2018
SAN DIEGO --(BUSINESS WIRE)--Nov. 1, 2018-- Tandem Diabetes Care ® , Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2018 . Third Quarter 2018 Results In comparing the third quarter of 2018 to
Displaying 1 - 20 of 186